Alastair Cribb

Alastair Cribb. He is a prominent veterinary pharmacologist and toxicologist known for his extensive research into drug metabolism and pharmacogenetics in companion animals and horses. His career has been primarily based at the University of Prince Edward Island and the University of Guelph, where his work has significantly advanced the field of veterinary clinical pharmacology. Cribb's research has directly influenced safer and more effective drug therapies in veterinary medicine, earning him recognition from organizations like the American College of Veterinary Clinical Pharmacology.

Early life and education

Alastair Cribb completed his undergraduate education in Canada, earning a Bachelor of Science degree. He then pursued his Doctor of Veterinary Medicine degree at the Ontario Veterinary College, a constituent college of the University of Guelph. Following his veterinary training, Cribb sought further specialization, completing a PhD in pharmacology and toxicology at the University of California, Davis, a leading institution in both veterinary science and biomedical research. His doctoral work laid the foundation for his future investigations into the mechanisms of drug biotransformation in animal species.

Academic career

After completing his PhD, Cribb returned to Canada to begin his academic career. He held a faculty position within the Department of Biomedical Sciences at the University of Guelph's Ontario Veterinary College. Later, he moved to the Atlantic Veterinary College at the University of Prince Edward Island, where he served as a professor and held leadership roles. Throughout his tenure, he has been actively involved with professional societies such as the American College of Veterinary Clinical Pharmacology and the Society of Toxicology. His teaching has influenced generations of veterinarians and graduate students in disciplines like pharmacokinetics and veterinary therapeutics.

Research and contributions

Cribb's research program has focused extensively on understanding species differences in the cytochrome P450 enzyme systems responsible for drug metabolism. His work on canine and feline pharmacogenetics has been pivotal, identifying genetic polymorphisms that affect responses to common medications like nonsteroidal anti-inflammatory drugs and anticonvulsants. He has conducted significant studies on drug-induced hepatotoxicity, particularly investigating adverse reactions to drugs such as carprofen in dogs. His collaborations with institutions like the University of Saskatchewan and researchers at North Carolina State University have expanded knowledge on therapeutic drug monitoring and adverse drug reactions across the pharmaceutical industry.

Awards and recognition

For his contributions to veterinary medical science, Alastair Cribb has received several prestigious awards. He is a recipient of the Pfizer Award for Research Excellence, a notable honor within veterinary research. His peers have further recognized his expertise through invitations to speak at major conferences, including those organized by the American Veterinary Medical Association and the European College of Veterinary Pharmacology and Toxicology. His body of work is widely cited in foundational texts and guidelines published by entities like the Journal of Veterinary Pharmacology and Therapeutics and the British Small Animal Veterinary Association.

Personal life

Outside of his professional endeavors, Alastair Cribb maintains a private personal life. He has been known to enjoy outdoor activities, appreciating the natural landscapes of Prince Edward Island and other regions of Atlantic Canada. His commitment to the field is reflected in his long-standing membership and contributions to academic and professional communities across North America and Europe.

Category:Canadian pharmacologists Category:Veterinary pharmacologists Category:University of Guelph alumni Category:University of California, Davis alumni Category:University of Prince Edward Island faculty